miR-191: An emerging player in disease biology

Frontiers in Genetics

Volumn 5, Issue APR, 2014, Pages

  Nagpal, Neha ^a   Kulshreshtha, Ritu ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Cancer; Diagnosis; Disease; MicroRNA; miR 191; Prognosis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIN D2; CYCLIN DEPENDENT KINASE 6; EARLY GROWTH RESPONSE FACTOR 1; ESTROGEN; FLUOROURACIL; MAX INTERACTING PROTEIN 1; MDM4 P53 BINDING PROTEIN; MICRORNA; MICRORNA 125B; MICRORNA 146B; MICRORNA 191; MICRORNA 191 3P; MICRORNA 191 5P; MICRORNA 21; MICRORNA 425; MICRORNA 425 3P; MICRORNA 425 5P; N DEACETYLASE; N SULFOTRANSFERASE 1; OXALIPLATIN; PEPTIDES AND PROTEINS; PROTEIN P53; RIO KINASE 3; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEASE 3; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CROHN DISEASE; GENE EXPRESSION; HUMAN; NEOPLASM; NEPHROTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR MICROENVIRONMENT;

EID: 84901010166     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00099     Document Type: Article

References (87)

1. Altuvia, Y., Landgraf, P., Lithwick, G., Elefant, N., Pfeffer, S., Aravin, A., et al. (2005). Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33, 2697-2706. doi: 10.1093/nar/gki567.
2. Bartel, D. P., and Chen, C. Z. (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5, 396-400. doi: 10.1038/nrg1328.
3. Brenu, E. W., Ashton, K. J., van Driel, M., Staines, D. R., Peterson, D., Atkinson, G. M., et al. (2012). Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Affect. Disord. 141, 261-269. doi: 10.1016/j.jad.2012.03.037.
4. Cai, S., Lee, C. C., and Kohwi-Shigematsu, T. (2006). SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 38, 1278-1288. doi: 10.1038/ng1913.
5. Caramuta, S., Egyházi, S., Rodolfo, M., Witten, D., Hansson, J., Larsson, C., et al. (2010). MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J. Invest. Dermatol. 130, 2062-2070. doi: 10.1038/jid.2010.63.
6. Cekaite, L., Clancy, T., and Sioud, M. (2010). Increased miR-21 expression during human monocyte differentiation into DCs. Front. Biosci. (Elite Ed.) 2:818-828. doi: 10.2741/E143.
7. Chaudhry, M. A., Omaruddin, R. A., Brumbaugh, C. D., Tariq, M. A., and Pourmand, N. (2013). Identification of radiation-induced microRNA transcriptome by next-generation massively parallel sequencing. J. Radiat. Res. 54, 808-822. doi: 10.1093/jrr/rrt014.
8. Choi, S. Y., Yun, J., Lee, O. J., Han, H. S., Yeo, M. K., Lee, M. A., et al. (2013). MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta 34, 799-804. doi: 10.1016/j.placenta.2013.06.006.
9. Colamaio, M., Borbone, E., Russo, L., Bianco, M., Federico, A., Califano, D., et al. (2011). miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting. J. Clin. Endocrinol. Metab. 96, E1915-E1924. doi: 10.1210/jc.2011-0408.
10. Crawford, B. E., Garner, O. B., Bishop, J. R., Zhang, D. Y., Bush, K. T., Nigam, S. K., et al. (2010). Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice. PLoS ONE 5:e10691. doi: 10.1371/journal.pone.0010691.
11. Croce, C. M. (2013). MiR-182-, miR-191, miR-199a-based methods for the diagnosis and prognosis of acute myeloid leukemia (AML), US 8431342.
12. Davidson, L. A., Wang, N., Shah, M. S., Lupton, J. R., Ivanov, I., and Chapkin, R. S. (2009). n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 30, 2077-2084. doi: 10.1093/carcin/bgp245.
13. Depamphilis, M. L., de Renty, C. M., Ullah, Z., and Lee, C. Y. (2012). "The octet": eight protein kinases that control mammalian DNA replication. Front. Physiol. 3:368. doi: 10.3389/fphys.2012.00368.
14. Di Leva, G., Piovan, C., Gasparini, P., Ngankeu, A., Taccioli, C., Briskin, D., et al. (2013). Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet. 9:e1003311. doi: 10.1371/journal.pgen.1003311.
15. Duan, Z., Choy, E., Harmon, D., Liu, X., Susa, M., Mankin, H., et al. (2011). MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol. Cancer Ther. 10, 1337-1345. doi: 10.1158/1535-7163.MCT-11-0096.
16. Elyakim, E., Sitbon, E., Faerman, A., Tabak, S., Montia, E., Belanis, L., et al. (2010). hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res. 70, 8077-8087. doi: 10.1158/0008-5472.CAN-10-1313.
17. Ernest, N., Chen, G., Chang, A. C., Lin, J., Reddy, R., Orringer, M. B., et al. (2012). Ratio of miR-146b/miR-191 in serum predicts prognosis in surgically resected lung squamous cell carcinomas. Cancer Res. 72:4147. doi: 10.1158/1538-7445.AM2012-4147.
18. Fassan, M., Baffa, R., Palazzo, J. P., Lloyd, J., Crosariol, M., Liu, C. G., et al. (2009). MicroRNA expression profiling of male breast cancer. Breast Cancer Res. 11:R58. doi: 10.1186/bcr2348.
19. Ferretti, E., De Smaele, E., Po, A., Di Marcotullio, L., Tosi, E., Espinola, M. S., et al. (2009). MicroRNA profiling in human medulloblastoma. Int. J. Cancer 124, 568-577. doi: 10.1002/ijc.23948.
20. Fulci, V., Colombo, T., Chiaretti, S., Messina, M., Citarella, F., Tavolaro, S., et al. (2009). Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes Cancer 48, 1069-1082. doi: 10.1002/gcc.20709.
21. Garzon, R., Volinia, S., Liu, C. G., Fernandez-Cymering, C., Palumbo, T., Pichiorri, F., et al. (2008). MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111, 3183-3189. doi: 10.1182/blood-2007-07-098749.
22. Gombos, K., Horváth, R., Szele, E., Juhász, K., Gocze, K., Somlai, K., et al. (2013). miRNA expression profiles of oral squamous cell carcinomas. Anticancer Res. 33, 1511-1517.
23. Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., and Enright, A. J. (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140-D144. doi: 10.1093/nar/gkj112.
24. Han, H. J., Russo, J., Kohwi, Y., and Kohwi-Shigematsu, T. (2008). SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452, 187-193. doi: 10.1038/nature06781.
25. He, Y., Cui, Y., Wang, W., Gu, J., Guo, S., Ma, K., et al. (2011). Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma. Neoplasia 13, 841-853.
26. Hui, A. B., Shi, W., Boutros, P. C., Miller, N., Pintilie, M., Fyles, T., et al. (2009). Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab. Invest. 89, 597-606. doi: 10.1038/labinvest.2009.12.
27. Inoue, T., Iinuma, H., Ogawa, E., Inaba, T., and Fukushima, R. (2012). Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol. Rep. 27, 1759-1764. doi: 10.3892/or.2012.1709.
28. Iorio, M. V., Ferracin, M., Liu, C. G., Veronese, A., Spizzo, R., Sabbioni, S., et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065-7070. doi: 10.1158/0008-5472.CAN-05-1783.
29. Izzotti, A., Calin, G. A., Arrigo, P., Steele, V. E., Croce, C. M., and De Flora, S. (2009). Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 23, 806-812. doi: 10.1096/fj.08-121384.
30. Kasashima, K., Nakamura, Y., and Kozu, T. (2004). Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem. Biophys. Res. Commun. 322, 403-410. doi: 10.1016/j.bbrc.2004.07.130.
31. Kashiwagi, M., Tortorella, M., Nagase, H., and Brew, K. (2001). TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 276, 12501-12504. doi: 10.1074/jbc.C000848200.
32. Kent, O. A., Mullendore, M., Wentzel, E. A., López-Romero, P., Tan, A. C., Alvarez, H., et al. (2009). A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol. Ther. 8, 2013-2024. doi: 10.4161/cbt.8.21.9685.
33. Kiezun, A., Artzi, S., Modai, S., Volk, N., Isakov, O., and Shomron, N. (2012). miRviewer: a multispecies microRNA homologous viewer. BMC Res. Notes 5:92. doi: 10.1186/1756-0500-5-92.
34. Kim, J., Krichevsky, A., Grad, Y., Hayes, G. D., Kosik, K. S., Church, G. M., et al. (2004). Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc. Natl. Acad. Sci. U.S.A. 101, 360-365. doi: 10.1073/pnas.2333854100.
35. Kumar, P., Dezso, Z., MacKenzie, C., Oestreicher, J., Agoulnik, S., Byrne, M., et al. (2013). Circulating miRNA biomarkers for Alzheimer's disease. PLoS ONE 8:e69807. doi: 10.1371/journal.pone.0069807.
36. Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A., and Tuschl, T. (2003). New microRNAs from mouse and human. RNA 9, 175-179. doi: 10.1261/rna.2146903.
37. Landi, M. T., Chatterjee, N., Caporaso, N. E., Rotunno, M., Albanes, D., Thun, M., et al. (2010). GPC5 rs2352028 variant and risk of lung cancer in never smokers. Lancet Oncol. 11, 714-716. doi: 10.1016/S1470-2045(10)70096-6.
38. Leite, K. R., Tomiyama, A., Reis, S. T., Sousa-Canavez, J. M., Sañudo, A., Camara-Lopes, L. H., et al. (2013). MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol. Oncol. 31, 796-801. doi: 10.1016/j.urolonc.2011.07.002.
39. Leite, K. R., Tomiyama, A., Reis, S. T., Sousa-Canavez, J. M., Sañudo, A., Dall'Oglio, M. F., et al. (2011). MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer. J. Urol. 185, 1118-1122. doi: 10.1016/j.juro.2010.10.035.
40. Lena, A. M., Mancini, M., Rivetti di Val Cervo, P., Saintigny, G., Mahé, C., Melino, G., et al. (2012). MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation. Biochem. Biophys. Res. Commun. 423, 509-514. doi: 10.1016/j.bbrc.2012.05.153.
41. Li, X., Zhang, Y., Zhang, H., Liu, X., Gong, T., Li, M., et al. (2011). miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res. 9, 824-833. doi: 10.1158/1541-7786.MCR-10-0529.
42. Lin, J., Cao, Q., Zhang, J., Li, Y., Shen, B., Zhao, Z., et al. (2013). MicroRNA expression patterns in indeterminate inflammatory bowel disease. Mod. Pathol. 26, 148-154. doi: 10.1038/modpathol.2012.131.
43. Liu, C., Iqbal, J., Teruya-Feldstein, J., Shen, Y., Dabrowska, M. J., Dybkaer, K., et al. (2013a). MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 122, 2083-2092. doi: 10.1182/blood-2012-08-447375.
44. Liu, J., Tang, X., Li, M., Lu, C., Shi, J., Zhou, L., et al. (2013b). Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility. Breast Cancer Res. Treat. 140, 151-157. doi: 10.1007/s10549-013-2615-x.
45. Liu, L., Fan, L., Fang, C., Zou, Z. J., Yang, S., Zhang, L. N., et al. (2012). S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia. Cancer Sci. 103, 2056-2063. doi: 10.1111/cas.12008.
46. Luo, Y., Wang, C., Chen, X., Zhong, T., Cai, X., Chen, S., et al. (2013). Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin. Chem. 59, 658-666. doi: 10.1373/clinchem.2012.195297.
47. Mar-Aguilar, F., Luna-Aguirre, C. M., Moreno-Rocha, J. C., Araiza-Chávez, J., Trevino, V., Rodriquez-Padilla, C., et al. (2013a). Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia Pac. J. Clin. Oncol. 9, 53-59. doi: 10.1111/j.1743-7563.2012.01548.x.
48. Mar-Aguilar, F., Mendoza-Ramírez, J. A., Malagón-Santiago, I., Espino-Silva, P. K., Santuario-Facio, S. K., Ruiz-Flores, P., et al. (2013b). Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis. Markers 34, 163-169. doi: 10.1155/2013/259454.
49. McEvoy, J., Ulyanov, A., Brennan, R., Wu, G., Pounds, S., Zhang, J., et al. (2012). Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma. PLoS ONE 7:e42739. doi: 10.1371/journal.pone.0042739.
50. Mellios, N., Huang, H. S., Grigorenko, A., Rogaev, E., and Akbarian, S. (2008). A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum. Mol. Genet. 17, 3030-3042. doi: 10.1093/hmg/ddn201.
51. Meng, W. J., Yan, H., Zhou, B., Zhang, W., Kong, X. H., Wang, R., et al. (2012). Correlation of SATB1 overexpression with the progression of human rectal cancer. Int. J. Colorectal Dis. 27, 143-150. doi: 10.1007/s00384-011-1302-9.
52. Monzo, M., Navarro, A., Bandres, E., Artells, R., Moreno, I., Gel, B., et al. (2008). Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 18, 823-833. doi: 10.1038/cr.2008.81.
53. Mueller, D. W., Rehli, M., and Bosserhoff, A. K. (2009). miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J. Invest. Dermatol. 129, 1740-1751. doi: 10.1038/jid.2008.452.
54. Na, Y. J., Sung, J. H., Lee, S. C., Lee, Y. J., Choi, Y. J., Park, W. Y., et al. (2009). Comprehensive analysis of microRNA-mRNA co-expression in circadian rhythm. Exp. Mol. Med. 41, 638-647. doi: 10.3858/emm.2009.41.9.070.
55. Nagpal, N., Ahmad, H. M., Molparia, B., and Kulshreshtha, R. (2013). MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis 34, 1889-1899. doi: 10.1093/carcin/bgt107.
56. Numakawa, T., Matsumoto, T., Numakawa, Y., Richards, M., Yamawaki, S., and Kunugi, H. (2011). Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. J. Toxicol. 2011:405194. doi: 10.1155/2011/405194.
57. Palmieri, A., Pezzetti, F., Brunelli, G., Martinelli, M., Lo Muzio, L., Scarano, A., et al. (2010). Anorganic bovine bone (Bio-Oss) regulates miRNA of osteoblast-like cells. Int. J. Periodontics Restorative Dent. 30, 83-87.
58. Pan, X., Zhao, J., Zhang, W. N., Li, H. Y., Mu, R., Zhou, T., et al. (2009). Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc. Natl. Acad. Sci. U.S.A. 106, 3788-3793. doi: 10.1073/pnas.0810147106.
59. Paraskevi, A., Theodoropoulosb, G., Papaconstantinouc, I., Mantzarisd, G., Nikitease, N., and Gazoulia, M. (2012). Circulating MicroRNA in inflammatory bowel disease. J. Crohns Colitis 6, 900-904. doi: 10.1016/j.crohns.2012.02.006.
60. Patel, R. S., Jakymiw, A., Yao, B., Pauley, B. A., Carcamo, W. C., Katz, J., et al. (2011). High resolution of microRNA signatures in human whole saliva. Arch. Oral Biol. 56, 1506-1513. doi: 10.1016/j.archoralbio.2011.05.015.
61. Patnaik, S. K., Kannisto, E., and Yendamuri, S. (2010). Overexpression of microRNA miR-30a or miR-191 in A549 lung cancer or BEAS-2B normal lung cell lines does not alter phenotype. PLoS ONE 5:e9219. doi: 10.1371/journal.pone.0009219.
62. Poliseno, L., Haimovic, A., Segura, M. F., Hanniford, D., Christos, P. J., Darvishian, F., et al. (2012). Histology-specific microRNA alterations in melanoma. J. Invest. Dermatol. 132, 1860-1868. doi: 10.1038/jid.2011.451.
63. Qin, S., Zhu, Y., Ai, F., Li, Y., Bai, B., Yao, W., et al. (2014). MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. Neoplasma 61, 27-34. doi: 10.4149/neo_2014_005.
64. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., et al. (2004). Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. U.S.A. 101, 9309-9314. doi: 10.1073/pnas.0401994101.
65. Robker, R. L., and Richards, J. S. (1998). Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol. Endocrinol. 12, 924-940. doi: 10.1210/mend.12.7.0138.
66. Saad, R., Chen, Z., Zhu, S., Jia, P., Zhao, Z., Washington, M. K., et al. (2013). Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS ONE 8:e64463. doi: 10.1371/journal.pone.0064463.
67. Saba, R., Goodman, C. D., Huzarewich, R. L., Robertson, C., and Booth, S. A. (2008). A miRNA signature of prion induced neurodegeneration. PLoS ONE 3:e3652. doi: 10.1371/journal.pone.0003652.
68. Scheffer, A. R., Holdenrieder, S., Kristiansen, G., von Ruecker, A., Müller, S. C., and Ellinger, J. (2014). Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J. Urol. 32, 353-358. doi: 10.1007/s00345-012-1010-2.
69. Shen, J., DiCioccio, R., Odunsi, K., Lele, S. B., and Zhao, H. (2010). Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer 10:47. doi: 10.1186/1471-2407-10-47.
70. Sheng, J., Liu, R., Xu, Y., and Liu, J. (2011). The dominating role of N-deacetylase/N-sulfotransferase 1 in forming domain structures in heparan sulfate. J. Biol. Chem. 286, 19768-19776. doi: 10.1074/jbc.M111.224311.
71. Shi, X., Su, S., Long, J., Mei, B., and Chen, Y. (2011). MicroRNA-191 targets N-deacetylase/N-sulfotransferase 1 and promotes cell growth in human gastric carcinoma cell line MGC803. Acta Biochim. Biophys. Sin. (Shanghai) 43, 849-856. doi: 10.1093/abbs/gmr084.
72. Taguchi, Y. H., and Murakami, Y. (2013). Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers. PLoS ONE 8:e66714. doi: 10.1371/journal.pone.0066714.
73. Vaz, C., Ahmad, H. M., Sharma, P., Gupta, R., Kumar, L., Kulshreshtha, R., et al. (2010). Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics 11:288. doi: 10.1186/1471-2164-11-288.
74. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 103, 2257-2261. doi: 10.1073/pnas.0510565103.
75. Wei, C., Henderson, H., Spradley, C., Li, L., Kim, I. K., Kumar, S., et al. (2013). Circulating miRNAs as potential marker for pulmonary hypertension. PLoS ONE 8:e64396. doi: 10.1371/journal.pone.0064396.
76. Wynendaele, J., Böhnke, A., Leucci, E., Nielsen, S. J., Lambertz, I., Hammer, S., et al. (2010). An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res. 70, 9641-9649. doi: 10.1158/0008-5472.CAN-10-0527.
77. Xi, Y., Formentini, A., Chien, M., Weir, D. B., Russo, J. J., Ju, J., et al. (2006). Prognostic values of microRNAs in colorectal cancer. Biomark. Insights 2, 113-121.
78. Xu, G., Zhang, Y., Jia, H., Li, J., Liu, X., Engelhardt, J. F., et al. (2009). Cloning and identification of microRNAs in bovine alveolar macrophages. Mol. Cell. Biochem. 332, 9-16. doi: 10.1007/s11010-009-0168-4.
79. Xu, L., Liang, Y. N., Luo, X. Q., Liu, X. D., and Guo, H. X. (2011). [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi 32, 178-181.
80. Yan, S. F., Pinsky, D. J., Mackman, N., and Stern, D. M. (2000). Egr-1: is it always immediate and early? J. Clin. Invest. 105, 553-554. doi: 10.1172/JCI9513.
81. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198. doi: 10.1016/j.ccr.2006.01.025.
82. Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., et al. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 107, 810-817. doi: 10.1161/CIRCRESAHA.110.226357.
83. Zhang, C., Liu, R., Wang, C., Ba, Y., Zhang, C., and Zeng, K. (2012). Pancreatic cancer markers, and detecting methods, kits, biochips thereof. EP 2518158.
84. Zhang, H., Luo, X. Q., Zhang, P., Huang, L. B., Zheng, Y. S., Wu, J., et al. (2009). MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE 4:e7826. doi: 10.1371/journal.pone.0007826.
85. Zhang, L., Flygare, J., Wong, P., Lim, B., and Lodish, H. F. (2011). miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1. Genes Dev. 25, 119-124. doi: 10.1101/gad.1998711.
86. Zhou, J., Zhou, Y., Yin, B., Hao, W., Zhao, L., Ju, W., et al. (2010). 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro. Oncol. Rep. 23, 121-128. doi: 10.3892/or_00000613.
87. Zhou, L., Zhang, X., Li, Z., Zhou, C., Li, M., Tang, X., et al. (2013). Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma. PLoS ONE 8:e64331. doi: 10.1371/journal.pone.0064331.